New Treatment Approaches For Mesothelioma With Biological Therapy

New Insights Into Immunotherapy for Mesothelioma

ByAlex Strauss May 13, 2016March 19, 2019

The development of excess fluid in the space around the lungs is a common side effect of malignant pleural mesothelioma.…

Cracking the Code: Calretinin's Role in Understanding Mesothelioma

Investigational Drugs May Offer New Ways to Treat Malignant Mesothelioma

ByAlex Strauss May 5, 2016March 16, 2017

There is some exciting news for patients fighting malignant mesothelioma this week. Two new potential mesothelioma drugs, both aimed at…

Biological Therapy | Europe | International | Research | Updates

Phenomenal Response to New Mesothelioma Immunotherapy Drug

ByAlex Strauss April 15, 2016March 16, 2017

There is some exciting news from the front lines of mesothelioma research this week. California scientists say they have dramatically…

Amatuximab May Extend Survival for Mesothelioma Patients on Chemotherapy

ByAlex Strauss March 4, 2016March 16, 2017

There is mounting evidence that the monoclonal antibody amatuximab could be used to make chemotherapy more effective for people with…

New Approach Enhances Mesothelioma Survival in Mice on Chemo

ByAlex Strauss February 10, 2016March 16, 2017

Even the best chemotherapy for malignant mesothelioma has limited effectiveness. But new research suggests that manipulating a mesothelioma patient’s RNA…

New Immunotherapy for Mesothelioma Relies on Altered T-Cells

ByAlex Strauss October 28, 2015March 16, 2017

An emerging type of mesothelioma therapy that uses altered T-cells to attack tumors is generating some excitement among researchers at…

Making Mesothelioma Cells More Susceptible to Chemotherapy

ByAlex Strauss August 22, 2015March 25, 2019

A potential new mesothelioma drug may have moved a step closer to gaining mainstream acceptance for use in sick patients.…

Immunotherapy's Impact on the Mesothelioma Immune System

Orphan Drug Approval Could Mean New Mesothelioma Treatment Option

ByAlex Strauss March 8, 2015March 26, 2019

A drug designed to fight cancer by destroying the stem cells that give rise to new cancer cells has been…

Targeting Estrogen Receptor Boosts Effectiveness of Mesothelioma Chemotherapy

ByAlex Strauss October 5, 2014March 16, 2017

Malignant mesothelioma is caused by exposure to asbestos and is notoriously hard to treat. The chemotherapy combination of cisplatin and…

Component in Spice May Help Slow Mesothelioma Growth

ByAlex Strauss September 24, 2014March 21, 2019

Yet another study has demonstrated the potential mesothelioma-fighting properties of curcumin, an anti-inflammatory polyphenol that is the primary component in…

1 (888) 378-1331

Biological Therapy

New Insights Into Immunotherapy for Mesothelioma

Investigational Drugs May Offer New Ways to Treat Malignant Mesothelioma

Phenomenal Response to New Mesothelioma Immunotherapy Drug

Amatuximab May Extend Survival for Mesothelioma Patients on Chemotherapy

New Approach Enhances Mesothelioma Survival in Mice on Chemo

New Immunotherapy for Mesothelioma Relies on Altered T-Cells

Making Mesothelioma Cells More Susceptible to Chemotherapy

Orphan Drug Approval Could Mean New Mesothelioma Treatment Option

Targeting Estrogen Receptor Boosts Effectiveness of Mesothelioma Chemotherapy

Component in Spice May Help Slow Mesothelioma Growth

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES